DK155247B - Analogifremgangsmaade til fremstilling af 1,8-dihydroxy-10-acyl-9-anthroner - Google Patents
Analogifremgangsmaade til fremstilling af 1,8-dihydroxy-10-acyl-9-anthroner Download PDFInfo
- Publication number
- DK155247B DK155247B DK136180AA DK136180A DK155247B DK 155247 B DK155247 B DK 155247B DK 136180A A DK136180A A DK 136180AA DK 136180 A DK136180 A DK 136180A DK 155247 B DK155247 B DK 155247B
- Authority
- DK
- Denmark
- Prior art keywords
- dihydroxy
- anthrons
- acyl
- anthralin
- compounds
- Prior art date
Links
- 238000000034 method Methods 0.000 title description 11
- NUZWLKWWNNJHPT-UHFFFAOYSA-N anthralin Chemical compound C1C2=CC=CC(O)=C2C(=O)C2=C1C=CC=C2O NUZWLKWWNNJHPT-UHFFFAOYSA-N 0.000 claims description 23
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 15
- 201000004681 Psoriasis Diseases 0.000 claims description 9
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 claims description 2
- 150000001412 amines Chemical class 0.000 claims description 2
- 239000012442 inert solvent Substances 0.000 claims description 2
- -1 pyridine Chemical class 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 description 17
- 229960002311 dithranol Drugs 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 238000002845 discoloration Methods 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 6
- 230000007794 irritation Effects 0.000 description 6
- 230000002757 inflammatory effect Effects 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- IPWOSICBVUXMML-UHFFFAOYSA-N (8,9-diacetyloxyanthracen-1-yl) acetate Chemical compound C1=CC(OC(C)=O)=C2C(OC(C)=O)=C3C(OC(=O)C)=CC=CC3=CC2=C1 IPWOSICBVUXMML-UHFFFAOYSA-N 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 125000003236 benzoyl group Chemical class [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 239000005662 Paraffin oil Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- 150000001454 anthracenes Chemical class 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- XSRNXRDVARVAJL-UHFFFAOYSA-N CCCC(=O)C1C2=C(C(=CC=C2)O)C(=O)C3=CC=CC=C13 Chemical compound CCCC(=O)C1C2=C(C(=CC=C2)O)C(=O)C3=CC=CC=C13 XSRNXRDVARVAJL-UHFFFAOYSA-N 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000005157 alkyl carboxy group Chemical group 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- YUTJCNNFTOIOGT-UHFFFAOYSA-N anthracene-1,8,9-triol Chemical class C1=CC(O)=C2C(O)=C3C(O)=CC=CC3=CC2=C1 YUTJCNNFTOIOGT-UHFFFAOYSA-N 0.000 description 1
- 230000002682 anti-psoriatic effect Effects 0.000 description 1
- 230000000561 anti-psychotic effect Effects 0.000 description 1
- 125000001231 benzoyloxy group Chemical group C(C1=CC=CC=C1)(=O)O* 0.000 description 1
- DVECBJCOGJRVPX-UHFFFAOYSA-N butyryl chloride Chemical compound CCCC(Cl)=O DVECBJCOGJRVPX-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- XGISHOFUAFNYQF-UHFFFAOYSA-N pentanoyl chloride Chemical compound CCCCC(Cl)=O XGISHOFUAFNYQF-UHFFFAOYSA-N 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 230000004526 pharmaceutical effect Effects 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- RZWZRACFZGVKFM-UHFFFAOYSA-N propanoyl chloride Chemical compound CCC(Cl)=O RZWZRACFZGVKFM-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical group 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/46—Friedel-Crafts reactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
- C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/42—Colour properties
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI791058A FI57743C (fi) | 1979-03-29 | 1979-03-29 | Foerfarande foer framstaellning av nya 1,8-dihydroxi-10-acyl-9-antroner mot psoriasis |
| FI791058 | 1979-03-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK136180A DK136180A (da) | 1980-09-30 |
| DK155247B true DK155247B (da) | 1989-03-13 |
Family
ID=8512535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK136180AA DK155247B (da) | 1979-03-29 | 1980-03-28 | Analogifremgangsmaade til fremstilling af 1,8-dihydroxy-10-acyl-9-anthroner |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4299846A (de) |
| EP (1) | EP0017420B1 (de) |
| AT (1) | AT363929B (de) |
| CA (1) | CA1124235A (de) |
| DE (1) | DE3060674D1 (de) |
| DK (1) | DK155247B (de) |
| FI (1) | FI57743C (de) |
| NO (1) | NO149630C (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2492372A1 (fr) * | 1980-10-21 | 1982-04-23 | Cird | Dihydroxy-1,8 anthrones-9 substituees en position 10 et leur utilisation en medecine humaine ou veterinaire et en cosmetique |
| FR2499556B1 (de) * | 1981-02-10 | 1983-03-25 | Cird | |
| FI66585C (fi) * | 1983-05-18 | 1984-11-12 | Orion Yhtymae Oy | Foerfarande foer framstaellning av saerskilt vid behandling avsoriasis anvaendbara 1,8-dihydroxi-10-acyl-9-antroner |
| US4843097A (en) * | 1984-06-13 | 1989-06-27 | Groupement D'interet Economique Dit: Centre International De Recherches Dermatologiques C.I.R.D. | 10-aryl-1,8-dihydroxy-9-anthrones and their esters, process for preparing same, and use of same in human and veterinary medicine and in cosmetics |
| FR2566772B1 (fr) * | 1984-06-29 | 1986-11-14 | Cird | Diacyloxy-1,8 acyl-10 anthrones, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique |
| FR2580631B1 (fr) * | 1985-04-17 | 1987-05-29 | Cird | Hydroxy-1 acyloxy-8 acyl-10 anthrones, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique |
| US5264577A (en) * | 1992-04-22 | 1993-11-23 | Warner-Lambert Company | Cyclic amino acids and derivatives thereof |
| DE4231636A1 (de) * | 1992-09-22 | 1994-03-24 | Beiersdorf Ag | Neue in 10-Stellung substituierte Anthron- und Anthracen-Derivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende pharmazeutische oder kosmetische Mittel und deren Verwendung |
| US5426197A (en) * | 1993-07-19 | 1995-06-20 | Teva Pharmaceutical Industries, Ltd. | 10-substituted 1,8-dihydroxy-9(10H) anthracenone pharmaceuticals |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4007271A (en) * | 1971-11-26 | 1977-02-08 | Sterling Drug Inc. | Dermatalogical compounds and compositions |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1935928A (en) * | 1928-10-17 | 1933-11-21 | Gen Aniline Works Inc | Alpha-hydroxyanthrone derivatives and process of preparing them |
| US2841596A (en) * | 1953-07-24 | 1958-07-01 | Pfizer & Co C | Cyclic ketones |
| GB1101028A (en) * | 1964-09-28 | 1968-01-31 | Givaudan & Cie Sa | Tricyclic compounds |
-
1979
- 1979-03-29 FI FI791058A patent/FI57743C/fi not_active IP Right Cessation
-
1980
- 1980-03-19 AT AT0149580A patent/AT363929B/de not_active IP Right Cessation
- 1980-03-24 CA CA348,277A patent/CA1124235A/en not_active Expired
- 1980-03-25 US US06/133,772 patent/US4299846A/en not_active Expired - Lifetime
- 1980-03-25 EP EP80300928A patent/EP0017420B1/de not_active Expired
- 1980-03-25 DE DE8080300928T patent/DE3060674D1/de not_active Expired
- 1980-03-28 DK DK136180AA patent/DK155247B/da not_active Application Discontinuation
- 1980-03-28 NO NO80800920A patent/NO149630C/no unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4007271A (en) * | 1971-11-26 | 1977-02-08 | Sterling Drug Inc. | Dermatalogical compounds and compositions |
Also Published As
| Publication number | Publication date |
|---|---|
| NO149630C (no) | 1984-05-30 |
| NO149630B (no) | 1984-02-13 |
| EP0017420B1 (de) | 1982-07-21 |
| FI57743B (fi) | 1980-06-30 |
| AT363929B (de) | 1981-09-10 |
| DE3060674D1 (en) | 1982-09-09 |
| NO800920L (no) | 1980-09-30 |
| CA1124235A (en) | 1982-05-25 |
| FI57743C (fi) | 1980-10-10 |
| EP0017420A1 (de) | 1980-10-15 |
| ATA149580A (de) | 1981-02-15 |
| US4299846A (en) | 1981-11-10 |
| DK136180A (da) | 1980-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3236871A (en) | 3, 5-dinitro-o-toluhydroxamic acid and esters and anhydrides thereof | |
| US4826996A (en) | 1,8,-dihydroxy-9-anthrones substituted in the 10-position | |
| DK155247B (da) | Analogifremgangsmaade til fremstilling af 1,8-dihydroxy-10-acyl-9-anthroner | |
| Rauhut et al. | The Preparation of Dithiophosphinates from Secondary Phosphines and Sulfur under Alkaline Conditions | |
| DE2356655B2 (de) | Substituierte Phenoxy- a -methylpropionsäure-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
| DE69525763T2 (de) | 4,6-DI-t-BUTYL-2,3-DIHYDROBENZOTHIOPHENE, DIE LDL OXIDATION HEMMEN | |
| IL35343A (en) | Process for the preparation of haloethyl phosphonic acids | |
| EP0006789A1 (de) | Bis(aryloxyalkancarbonsäure)verbindungen, ihre Herstellung und ihre therapeutische Verwendung | |
| DK154207B (da) | Fremgangsmaade til fremstilling af 1,8-dihydroxy-10-acyl-9-anthroner | |
| DE2854877A1 (de) | N-substituierte omega-thiobutyramide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel | |
| US4275068A (en) | Lipid lowering alkylene glycols and ester derivatives thereof | |
| US4866095A (en) | 1,8-dihydroxy-9-anthrones for treating warts or psoriasis | |
| US3742043A (en) | 2-(alpha,alpha-bis(trifluoromethyl)benzyloxy) acetic acid and esters thereof | |
| EP0007347B1 (de) | Lipidsenkende Alkylenglykolderivate und Verfahren zu ihrer Herstellung | |
| US691157A (en) | Trimethyl hexahydroöxybenzylanilin and process of making same. | |
| US2847460A (en) | 6-methyl-3-cyclohexene-1-acrylic acid | |
| US4086343A (en) | Acylated hydrazinopyridazine antihypertensives | |
| DE2542413C3 (de) | Verfahren zur Herstellung von GIykol-2-(p-chlorphenoxy)-2-methylpropionatnicotinat | |
| SU150792A1 (ru) | Способ получени алкокеиметиленамидов 0,0-диалкилтио- и 0,0-диалкилдитиофосфорилуксусной кислоты | |
| DE1814334B2 (de) | Fettsaeureamide und diese verbindungen enthaltende arzneimittel | |
| JPS61103881A (ja) | ４−チアゾリジノン誘導体及びその製造方法 | |
| CH622787A5 (en) | Process for the preparation of benzamides | |
| RU2712914C2 (ru) | Бис-(4,5-оксиметил-2-метил-3-окси)пиридиниевая соль 2-нитрокси-бутан-1,4-диовой кислоты и способ его получения | |
| DE1271667B (de) | Verfahren zum Widerstandsfaehigmachen von Textilien aus Cellulose gegenueber Mikroorganismen | |
| DE2316921C3 (de) | Verfahren zur Herstellung von substituierten 1,3-DHhia-2-methylencycloalkanen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PHB | Application deemed withdrawn due to non-payment or other reasons |